AFT Pharmaceuticals Limited (AFP) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aft Pharmaceuticals Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.156 Good day, my name is Krista and I'll be your conference operator today. 00:00:04.156 -- 00:00:10.445 At this time, I would like to welcome everyone to the fiscal year 2024 half-year 00:00:10.445 -- 00:00:15.511 results analyst briefing. All lines have been placed on mute to prevent any 00:00:15.511 -- 00:00:20.458 background noise. After the speaker's remarks, there will be a question and answer session. 00:00:20.458 -- 00:00:25.284 If you would like to ask a question during that time, please press star followed by the 00:00:25.284 -- 00:00:29.627 number one on your telephone keypad. And if you would like to withdraw your question, 00:00:29.627 -- 00:00:35.013 again, press star one. Thank you. I will now turn the conference over to Hartley Atkinson, 00:00:35.013 -- 00:00:39.718 Managing Director. Hartley, you may begin your conference. 00:00:39.718 -- 00:00:43.282 Good. Thank you very much. And thank you, everyone, for joining us today. 00:00:43.282 -- 00:00:48.868 So just to do the usual format where we go through the investor presentation and 00:00:48.868 -- 00:00:54.134 then we have question time. So, look, just to start, just go through the page 00:00:54.134 -- 00:00:59.294 numbers. So we've got the cover page. which we're going through the results 00:00:59.294 -- 00:01:05.522 for our first half of the financial year, which ended the 30th of September. 00:01:05.522 -- 00:01:11.590 And on page two, we had the usual disclaimer, so please just be aware of those details 00:01:11.590 -- 00:01:17.718 on page two. Page three, the people presenting today will be a mixture of myself 00:01:17.718 -- 00:01:22.805 and also Malcolm Tubby, our Chief Financial Officer, will cover the financial 00:01:22.805 -- 00:01:28.098 pages of the present...